Euro
USD
British Pound
NULL
Product Description
Anlotinib (AL3818) is a novel multitarget tyrosine kinase inhibitor, inhibiting tumor angiogenesis and proliferative signaling. Potential antineoplastic and anti-angiogenic agent.
Anlotinib (AL3818) is a novel multitarget tyrosine kinase inhibitor, inhibiting tumor angiogenesis and proliferative signaling. Potential antineoplastic and anti-angiogenic agent.
Biovision | B2156 | Anlotinib, free base DataSheet
Alternate Name/Synonyms: 1-(((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinolin-7-yl)oxy)methyl)cyclopropan-1-amine; AL3818
Appearance: Cystalline solid
Formulation: N/A
CAS Number: 1058156-90-3
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₃H₂₂FN₃O₃
Molecular Weight: 407.44
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A novel multitarget tyrosine kinase inhibitor
MDL Number: N/A
PubChem CID: 25017411
SMILES: CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC
InChi: InChI=1S/C23H22FN3O3/c1-13-9-15-16(27-13)3-4-19(22(15)24)30-18-5-8-26-17-11-21(20(28-2)10-14(17)18)29-12-23(25)6-7-23/h3-5,8-11,27H,6-7,12,25H2,1-2H3
InChi Key: KSMZEXLVHXZPEF-UHFFFAOYSA-N
